Abstract
Vitamin D and vitamin D metabolites such as 25-hydroxyvitamin D and 1α,25-dihydroxyvitamin D [1α,25(OH)2D3] circulate in the serum of fish. The receptor for 1α,25(OH)2D3 (VDR) has previously been cloned from fish intestine, and ligand binding assays have shown the presence of the VDR in the gills, intestine, and liver of fish. Using immunohistochemical methods with specific antibodies against the VDR, we now report that the VDR is widely expressed in tissues of the adult male and female zebrafish, Danio rerio, specifically in epithelial cells of gills, tubular cells of the kidney, and absorptive cells in the intestine. Additionally, the VDR is expressed in the skin, the olfactory organ, the retina, brain, and spinal cord. Sertoli cells of the testis, oocytes, acinar cells of the pancreas, hepatocytes, and bile duct epithelial cells express substantial amounts of the receptor. Osteoblast-like cells and chondrocytes also express VDR. Preimmune serum and antiserum preadsorbed with Danio VDR protein fails to detect VDR in the same tissues. The VDR is also present in the developing eye, brain, and otic vesicle of 48- and 96-h postfertilization zebrafish embryos. Parenteral administration of 1α,25(OH)2D3 increases concentrations of VDR in intestinal epithelial cells but not in epithelial cells of the gills. Lithocholic acid, however, does not alter concentrations of VDR after parenteral administration. The data suggest that VDR is widely distributed in tissues of the zebrafish, D. rerio, and is likely to play important roles in epithelial transport, bone, and endocrine function. Furthermore, concentrations of the receptor seem to be regulated by its ligand, 1α,25-dihydroxyvitamin D but not by lithocholic acid. Zebrafish may serve as a useful model in which to assess the function of the VDR in diverse tissues.
Key words: zebrafish, vitamin D receptor, 1α, 25-dihydroxyvitamin D, calcium
INTRODUCTION
The vitamin D endocrine system plays a vital role in mineral homeostasis, endocrine, immune, and neural function.(1–5) The active metabolite of vitamin D3, 1α,25(OH)2D3, is formed from vitamin D3 as a result of a multistep process involving hydroxylations at C-25 and C-1 that occur in the liver and kidney, respectively.(1,2) 1α,25(OH)2D3 binds to its receptor, the vitamin D receptor (VDR), with high affinity and subsequently regulates the expression of several genes.(4) The crucial role of VDR in mediating the function of 1α,25(OH)2D3 is shown by the occurrence of disordered calcium and phosphorous homeostasis in humans and animal models that have mutations of the VDR.(6–9)
Previous immunohistochemical studies from our laboratory have shown that VDR is present in several epithelial tissues of terrestrial mammals.(10–16) However, little is known of the distribution of VDR in fish. Fish are a source of vitamin D3(17–19) and have detectable concentrations of 25-hydroxyvitamin D3 and 1α,25(OH)2D3 in serum.(20–23) Two species of VDR have been cloned from the intestine of the flounder and pufferfish,(24,25) and VDR is present in the lamprey, a fish lacking skeletal elements, suggesting that VDR may play a role in processes other than bone mineralization such as xenobiotic metabolism.(26,27) Published literature suggests that Danio rerio, however, expresses a single VDR, although sequencing of expressed RNA suggests some heterogeneity in the sequence.(26,28–30) 1α,25(OH)2D3 alters mineral transport in fish gills, and vitamin D deficiency is associated with altered growth and mineralization of the fish skeleton.(31–33) Indeed, changes in 1α,25(OH)2D3 and VDR concentrations have been noted in salmon undergoing smoltification and migrating from freshwater (low calcium concentrations) to seawater (high calcium concentrations), suggesting that synthesis of the sterol and its receptor undergo alterations depending on ambient calcium concentrations.(32) Furthermore, the administration of vitamin D3 or 1α,25-dihydroxyvitamin D3 is associated with increased mineralization in developing fish embryos.(34) There have been no reports, however, that have examined the organ-specific and cellular distribution of the VDR in tissues of fish using specific antibodies.
To establish the zebrafish, D. rerio, as a model organism in which to study the multiple effects of 1α,25(OH)2D3, we examined the distribution of the VDR in adult male and female fish and in developing fish embryos. D. rerio is an important model organism in which disruption of gene expression often results in a phenotype that can be readily observed. Additionally, the effects of exposure to toxins and other xenobiotics can be readily observed in this organism, and the effects of disruptions of key proteins in the adaptation to exposure to xenobiotics can be assessed.(35) We now show that the VDR is present in multiple epithelial tissues such as the gill, kidney, and intestine, which are important in the movement of calcium and other ions. In addition, we show that the VDR is present in bone and endocrine tissues such as the pancreas, testis, and ovary, suggesting that 1α,25(OH)2D3 may be important in the appropriate function of these organs. The VDR is detected in the brain, retina, and olfactory organs, suggesting that it may be important in their function. We also show that the VDR is present in the developing fish embryo. In adult fish, the parenteral administration of 1α,25(OH)2D3 increases VDR expression in the intestine but not in gills. Lithocholic acid does not increase VDR concentrations in the intestine or gills when administered parenterally in fish.
MATERIALS AND METHODS
Expression methods for Danio rerio VDR 33-453
RT-PCR was carried out using a Titanium One Step RT PCR kit (Clontech, Mountain View, CA, USA) to obtain a full-length cDNA clone for D. rerio VDR (GenBank accession NM_130919) using total RNA prepared from D. rerio. Appropriate primers contained BamHI and EcoRI restriction sites to allow for subsequent cloning into an expression plasmid. PCR products for 33-453 D. rerio Q47E P54R VDR (which corresponds, in length, to residues in full-length [FL] human VDR) were treated with BamHI and EcoRI and ligated into BamHI/EcoRI-treated pGEX-6P-1 (GE Amersham Biosciences, Piscataway, NJ, USA). E. coli BL21 host cells (Novagen/EMD) were transformed with the VDR-pGEX-6P-1 chimeric plasmid for subsequent protein expression. The DNA sequence was verified by sequencing both strands of the plasmid constructs. The 33-453 VDR of D. rerio was expressed using bacterial expression methods for the VDR.(36–39) Briefly, the D. rerio VDR construct was expressed as a glutathione S-transferase (GST) fusion protein. E. coli BL21 cells were transformed with the expression plasmid and were plated on antibiotic plates, and single colonies were grown in 100-ml starter cultures in 2× YT medium with appropriate antibiotic (ampicillin 100 μg/ml). Ten liters of 2× YT medium with appropriate antibiotic were inoculated with starter cultures, and cells were grown to an OD600 of ∼1 at 37°C. The temperature was decreased to 20°C for 30 min, and isopropylthiogalactoside (IPTG) was added to a concentration of 0.1 mM. Cells were allowed to grow for ∼5 h, and bacterial pellets were harvested by centrifugation. Bacteria were lysed in PBS, 5 mM EDTA, and 10 mM β-mercaptoethanol (β-ME), pH 7.4 (lysis buffer) containing 4 mM phenylmethylsulfonylfluoride (PMSF) using 0.1-mm glass beads and an ice-jacketed bead beater (Biospec Products, Bartlesville, OK, USA). Bacterial lysates, from bacteria expressing the GST-VDR, were centrifuged at 20,000g, and the clarified supernatants were applied to glutathione-Sepharose using a batch procedure at 4°C for ∼1.5 h (Clontech; Miltenyi Biotec, Auburn, CA, USA). The matrix was washed extensively with lysis buffer at 4°C, followed by washes with PBS and 10 mM β-ME. The glutathione resin (7.5 ml) to which GST-VDR was bound was washed with 150 ml of 50 mM Tris, 1 mM DTT, 1 mM EDTA, and 150 mM NaCl, pH 7.0. The resin with GST-VDR bound to it was treated with 60 units of PreScission Protease (GE Amersham Biosciences) at 4°C. D. rerio 33-453 VDR was collected after cleavage was complete (as determined by SDS-PAGE) by addition of PreScission Protease buffer and collection of the column effluent. D. rerio 33-453 VDR was further purified by dilution of the protein with 6 volumes of 50 mM Tris and 2 mM DTT, pH 7.0 (buffer A), which was filtered through a 0.2-μm nylon filter. The protein was applied to a Tricorn MonoQ 50/5 column (GE Amersham Biosciences). Highly purified D. rerio 33-453 VDR was eluted by a gradient of increasing amounts of buffer B (buffer A containing 1 M NaCl). The pure protein eluted at ∼32% buffer B. Protein purity was assessed by SDS-PAGE using Coomassie blue and silver-stained Phastgels (GE Amersham Biosciences, and by Western analyses using rabbit anti-human VDR (2-152) and anti-rabbit horseradish peroxidase–conjugated IgG secondary antibody (Dako, Carpinteria, CA, USA). Bound secondary antibody was detected by use of a chemiluminescence substrate (Roche Diagnostics, Indianapolis, IN, USA).
Fixation of zebrafish for immunohistochemistry
Adult male and female zebrafish (∼5 mo of age) raised under standard conditions in fish water (Instant Ocean; Spectrum, Atlanta, GA, USA; final conductivity 450 μS/cm2, pH 7.5; final calcium concentration, 0.25 mM) were obtained from Dr Xiaolei Xu (Department of Biochemistry and Molecular Biology, Mayo Clinic). The fish were fed brine shrimp four times per day. The fish were killed with 1% tricaine in fish water. A slit was cut in the ventral portion of the abdomen using a sharp scalpel. The fish were placed in Dietrich's solution (30% ethanol, 10% formalin, and 2% acetic acid, pH 2.7) for decalcification and fixation at room temperature for 96 h. The fixed and decalcified fish were embedded in paraffin and serially sectioned to obtain 4-μm sections.
Forty-eight- and ninety-six-hour postfertilization zebrafish embryos were fixed as previously described.(10,14)
Immunohistochemistry using VDR antibody
Immunohistochemistry for VDR was performed using methods described earlier.(10,12–16) VDR antibodies were prepared as described earlier.(10,12–16) Four-micrometer-thick serial sections from adult fish were placed on silanized slides. The slides were deparaffinized in xylene, rehydrated in a series of ethanol solutions, and rinsed in water. Endogenous peroxidase activity was blocked using 0.6% H2O2 in methanol. After a water rinse, sections were placed in 10 mM citric acid, pH 6.0, and heated in a microwave two times for 2 min in a 750-W oven set on high. After cooling, sections were treated with 5% normal goat serum in PBS, pH 7.4, containing 0.05% Tween 20 for 15 min and incubated for 60 min with rabbit-anti-VDR, at a dilution of 1:500 or 1:1000, at room temperature. After rinsing, sections were treated with biotinylated goat anti-rabbit immunoglobulin G (1:200; Dako), followed by peroxidase-labeled streptavidin (1:500; Dako) for 30 min at room temperature. Sections were developed by adding 0.1 M sodium acetate, pH 5.2, containing aminoethyl carbazole and H2O2 for 15 min. Sections were counterstained with hematoxylin and placed on a coverslip with aqueous mounting media. Negative controls for nonspecific staining were done on tissue sections using preimmune rabbit serum diluted 1:500 in place of primary antibodies. To assure specificity, slides were also stained using primary antibodies that were preadsorbed with Danio VDR antigen or VDR buffer (as control) prepared as described above.
Immunofluorescence fixation and labeling
Adult zebrafish for immunofluorescence were obtained from Jennifer Liang (Case Western Reserve University). Fish were fixed in 4% paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA, USA) in PBS overnight at 4°C followed by incubation in 30% sucrose in PBS overnight at 4°C. Fish were embedded in Tissue Tek (Electron Microscopy Sciences) and cut in 20-μm sections on a Leica cryotome. Frozen sections for fluorescence labeling were rehydrated in PBS and blocked in goat blocking buffer (5% normal goat serum, 1% glycerol, 0.1% each fish skin gelatin, and BSA in PBS, pH 7.2). Sections were incubated with rabbit anti-VDR (1/1000) 2 h at room temperature followed by Cy5 conjugated goat anti-rabbit IgG (1/800; Invitrogen, Carlsbad, CA, USA) for 1 h at room temperature.
Regulation of VDR by 1α,25(OH)2D3 and lithocholic acid
Adult male fish were administered intramuscularly 25 ng of 1α,25(OH)2D3 (Dr Milan Uskokovic, Roche, Nutley, NJ, USA) in 5 μl propylene glycol, 25 ng of lithocholic acid (Sigma Chemicals, St Louis, MO, USA) in 5 μl propylene glycol, or 5 μl of propylene glycol alone. Twenty-two hours later, the fish were killed in tricaine as described above, and sections of fish containing the intestine and gills were isolated by a transverse cut behind the gill operculum and homogenized in buffer containing 50 mM Tris, 25 mM sodium chloride, 6 mM EDTA, and 10 mM DTT, pH 7.4, containing a protease-inhibitor cocktail (Roche Diagnostics). The homogenates were centrifuged at 16,000g at 4°C for 1 h. The supernatant protein was quantitated in each sample using Bio-Rad protein reagent (Bio-Rad, Hercules, CA, USA), and 60 μg of protein homogenate was separated by SDS-PAGE. The separated proteins were transferred to PVDF membranes and exposed to anti-VDR antibody (1:500) in TBS (50 mM Tris, 150 mM sodium chloride, pH 7.5) containing 0.5% blocking agent (Roche) for 1 h. The membranes were washed three times in TBS, 0.1% Tween-20 and exposed to secondary antibody (goat-anti-rabbit HRP-IgG; Dako, Carpinteria, CA, USA; 1:2000, in TBS containing 0.5% blocking agent) for 1 h. The membrane was washed three times in TBS and 0.1% Tween-20. The membrane was exposed to BM chemiluminescent reagent (Roche Diagnostics) for 1 min. Signal was detected by exposing the membranes to X-ray film (Biomax MR). The optical density of bands at Mr 52,000 was quantitated using a Kodak ds-1D Digital System Version 3.0.0 (Kodak, New Haven, CT, USA).
RESULTS
A low-power view of the sagittally sectioned posterior portion of an adult male zebrafish showed the presence of VDR in the intestine (I), liver (L), testis (T), and kidney (K) (Fig. 1A). Studies performed with the preimmune serum showed absent staining in these organs (Fig. 1B). A low-power view of the sagittally sectioned midportion of an adult male zebrafish showed immunostaining for the VDR in the gills (G), epithelium of the oropharynx, and brain (B) (Fig. 1C). A low-power view of a transverse section of the midportion of an adult male zebrafish showed staining for the VDR in the gills (G), epithelium of the oropharynx (O), and spinal cord (SC) (Fig. 1D). A low-power view of the sagittally sectioned anterior portion of an adult zebrafish showed the presence of the VDR in layers of the eye (E) and olfactory organ (OO) (Fig. 1E). Figure 1F shows the absence of immunostaining using preimmune serum.
To assure specificity of the antibody, anti-VDR immune serum was preadsorbed with excess D. rerio recombinant VDR. No immunostaining was observed using preadsorbed VDR antibody in the intestine (Fig. 2A), kidney or liver (Fig. 2B), gill membranes or oropharynx (Fig. 2C), testis (Fig. 2D), or the various layers of the eye (Fig. 2E).
In the kidney, immunostaining is visible in the renal tubules (T) and the glomerular epithelium (G) (Fig. 3A). Immunostaining is present throughout the tubular cell and is not exclusively localized to the nucleus. There is no staining visible in the kidney when preimmune serum is used (Fig. 3B). In Fig. 3C, immunostaining for VDR is clearly visible in epithelial cells of gill lamellae (L). Additionally, immunostaining for the VDR is visible in chondrocyte cells of the bony portion of the filaments of the gill (CC in F; see discussion below regarding distribution in bone). Preimmune serum shows the appropriate negative results for VDR immunostaining (Fig. 3D). Figure 3E shows immunostaining for VDR with immune serum in the epithelial cells of the olfactory organ (OOE, arrows). Results with preimmune serum are appropriately negative (Fig. 3F). There is intense staining for VDR in epithelial cells of the intestine (EC; Fig. 3G). The bodies of goblet cells that contain mucin-like material immunostain with VDR antibodies. The mucinous material does not immunostain. Results with the preimmune serum were negative (Fig. 3H). Of note, as shown in Fig. 2, preadsorbed antiserum reveals no immunostaining in various organs.
Besides epithelial cells, VDR is also detected in acinar cells of the pancreas (AC; Fig. 4A). Interestingly, VDR immunostaining is faint or absent in islet cells of the pancreas (I; Fig. 4A). In bone, osteoblasts stain intensely for VDR (Ob; Fig. 4B). VDR immunostaining is also present in hepatocytes and cholangiocytes (epithelial cells lining the biliary ductules) of the liver (Hc and Cc; Fig. 4C). Preimmune serum shows no immunostaining for VDR in the liver (Fig. 4D). Similar results were obtained with preadsorbed serum. In the heart, no immunostaining for VDR is noted in myocytes (compare Fig. 4E with Fig. 4F). Staining in the chambers of the heart is probably caused by peroxidase activity exhibited by red cells and not blocked sufficiently by peroxide pretreatment. In Fig. 4G, VDR immunostaining in Sertoli cells in the testis is shown. Preimmune serum shows no VDR immunostaining in testicular cells (Fig. 4H).
In adult female fish all tissues except reproductive tissues immunostained for VDR in a manner identical to that seen in adult male fish. In the female ovary, VDR immunostaining was noted in developing and mature ovarian follicles (Fig. 5A). No signal was noted with preimmune serum (Fig. 5B). An example of positive immunostaining in nonreproductive, adult female zebrafish tissue (gills) is seen in Fig. 5C. No VDR signal was noted when preimmune serum was used to immunostain gills (Fig. 5D).
VDR immunostaining is also evident in the ganglion cell layer of the retina (a), the inner plexiform layer (b), the inner nuclear layer (c), the outer plexiform layer (d), the outer nuclear layer (e), and the photo receptor layer (f) (Fig. 6A). No immunostaining is discerned in the retinal pigmented layer (g). In contrast, no staining is observed with preimmune serum (Fig. 6B). VDR immunostaining is observed in cells of the brain and spinal cord (Figs. 6C, 6E, and 6F). No immunostaining is noted with preimmune serum (Fig. 6D).
We used an alternative technique to show VDR immunostaining in bone, retina, neural tissue, and gills. Fluorescent labeling is seen in the spinal cord (SC) and cancellous bone of the vertebral body (boxed area; Fig. 7A). The location and number of the cells labeled in the vertebral body suggests these cells are osteoblasts (Fig. 7B). The absence of deep labeling in the cortical bone is likely caused by lack of penetration of antibodies deep within the dense cortical bone. VDR fluorescent immunostaining is also evident in the ganglion cell layer of the retina (a), the inner plexiform layer (b), the inner nuclear layer (c), the outer plexiform layer (d), the outer nuclear layer (e), and the photoreceptor layer (f) (Fig. 7C). Immunofluorescence studies show intense labeling of VDR at the dorsal surface of the gills (Fig. 7D).
We examined the distribution of VDR in 48- and 96-h postfertilization zebrafish embryos. In the 48-h postfertilization embryo, VDR is seen in the developing brain (diencephalon) and in cells of the neural retina (Fig. 8A, coronal section; Fig. 8B, sagittal section). VDR is also seen the developing mandible (Figs. 8A and 8B). No immunostaining was observed in similar cells when preimmune serum was used (Fig. 8C). Figure 9A shows results obtained with immune serum in 96-h postfertilization embryos. VDR immunostaining is observed in the eye (E), portions of the brain (B), and the otic vesicle (O). Preimmune serum failed to show the presence of VDR (Fig. 9B). A higher-magnification view of the developing eye is seen in Fig. 9C. Cells of the lens (L) do not immunostain. Ganglion cells appear to immunostain (G). Rods (R) do not immunostain. Cells lining the otic vesicle (OE) immunostain for VDR (Fig. 8D).
We studied whether VDR in zebrafish is regulated by its ligands, 1α,25(OH)2D3 and lithocholic acid. We administered 25 ng of 1α,25(OH)2D3, lithocholic acid, or vehicle intramuscularly into male zebrafish. We observed an upregulation of VDR in intestinal tissues (Fig. 10; p < 0.05) after administration of 1α,25(OH)2D3 but not lithocholic acid.
DISCUSSION
We showed widespread expression of VDR in epithelial solute transporting tissues of the zebrafish, D. rerio. Immunostaining for VDR is found in tissues such as the intestine, liver, and gills where specific 1α,25(OH)2D3 ligand binding had been previously detected by Sundell et al.(23) Our findings show that specific cells in these organs immunostain for VDR. For example, in the intestine, both absorptive cells and goblet cells appear to stain for VDR. In the gills, absorptive epithelium present on gill lamellae expresses VDR. Interestingly, chondrocytes present in gill filaments also stain for VDR. We show that VDR is present both in tubular epithelial cells and in epithelial cells of the glomerulus. This is consistent with findings in the rat kidney reported by us earlier.(14) Sundell et al. did not detect the presence of the VDR in the kidney.(23) The reason for this discrepancy is uncertain but may be caused by the relative insensitivity of ligand binding assays compared with immunostaining methods used by us in this report. It is very likely that the VDR plays an important role in the regulation of calcium and phosphorous transport in epithelial cells of the zebrafish intestine, kidney, and gills. Indeed, Qiu et al.(31) have shown that 1α,25(OH)2D3 increases the uptake of zinc in the gills, and it has been shown that vitamin D deficiency alters mineral metabolism and bone development in fish, suggesting an important role for VDR in calcium transport in the intestine. In the liver, both hepatocytes and cholangiocytes, which have widely differing biochemical functions, express VDR. Cholangiocytes (biliary duct epithelial lining cells) also transport solutes and water, and the presence of VDR in these cells suggests that it may function to control solute transport in these cells in a manner similar to that observed in transporting epithelia of the intestine, kidney, and gills. The effects of 1α,25(OH)2D3 on the transport of minerals and other solutes in transporting epithelia of Danio warrants further study.
The VDR is also expressed in endocrine cells such as the acinar cells of the pancreas. Interestingly, in contrast to what is found in mammals and birds,(10,40–42) immunostaining in pancreatic islets of the zebrafish is minimal. These data suggest that VDR does not play a role in modulating insulin secretion in Danio but plays a role in altering pancreatic secretions through its actions on acinar cells. Alternatively, low levels of VDR may be present in islet cells but are not detected by our antibody. VDR is also expressed in Sertoli cells in the testis and in developing oocytes in ovarian tissue, suggesting role for the VDR and vitamin D-endocrine system in reproductive function in male Danio. Other than the distribution of VDR in either testis or ovary, VDR distribution is identical in male and female zebrafish.
The bone is a major target of 1α,25(OH)2D3, independent of the effect of the hormone on concentrations of calcium and phosphorus in the extracellular fluid. Both osteoblast and osteoclast function is affected by the hormone. We showed the presence of VDR in both chondrocytes and osteoblasts. The precise biochemical events modulated by 1α,25(OH)2D3 in these cells in Danio remains to be determined.
Previous reports have shown the presence of the VDR in cells of the nervous system.(43–46) We show that, in the zebrafish, VDR expression is observed in cells of the brain, spinal cord, and epithelial cells of the olfactory organ. Of interest, the VDR is expressed in the adult zebrafish eye in ganglion cells, inner nuclear layer cells, and rods in the retina. The exact role of VDR in the different parts of the nervous system of the fish remains to be elucidated. The zebrafish may be well suited to study the effects of VDR on nervous system development.
To determine whether VDR is expressed in the developing zebrafish embryo, we sectioned 48-and 96-h postfertilization zebrafish embryos and immunostained them with VDR antibodies. We observed VDR immunostaining in the developing brain, in epithelial cells lining the otic vesicle, and in the ganglion cells of eye. We did not examine earlier stages of development (<48 h postfertilization), because immunohistochemistry at earlier time points is technically difficult. Other methods (e.g., in situ hybridization) may yield information regarding VDR distribution and expression in very early developing zebrafish embryos.
To gain insights into the regulation of VDR, we administered either 1α,25(OH)2D3 or lithocholic acid parenterally to determine whether these ligands modulate VDR concentrations in various tissues. We observed that 1α,25(OH)2D3 increased VDR expression in the intestine but not in the gill. Lithocholic acid was without effect.
In conclusion, VDR is widely expressed in epithelial endocrine and neural tissues of the male and female adult zebrafish, D. rerio. It is also expressed in developing embryos of the zebrafish as early as 48 h postfertilization. VDR concentrations in the intestine are modulated by 1α,25(OH)2D3. These data suggest an important role of VDR in fish biology. The zebrafish is a novel and readily manipulated model system in which to further explore the biology of VDR.
ACKNOWLEDGMENTS
This work was supported by NIH Grants DK 65830, DK 76829, and DK 73369 (to RK) and AHA Grant 0630137N (to CRS).
Footnotes
The authors state that they have no conflicts of interest.
REFERENCES
- 1.DeLuca HF, Schnoes HK. Vitamin D: Recent advances. Annu Rev Biochem. 1983;52:411–439. doi: 10.1146/annurev.bi.52.070183.002211. [DOI] [PubMed] [Google Scholar]
- 2.DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004;80:1689S–1696S. doi: 10.1093/ajcn/80.6.1689S. [DOI] [PubMed] [Google Scholar]
- 3.Norman AW. Minireview: Vitamin D receptor: New assignments for an already busy receptor. Endocrinology. 2006;147:5542–5548. doi: 10.1210/en.2006-0946. [DOI] [PubMed] [Google Scholar]
- 4.Jurutka PW, Whitfield GK, Hsieh JC, Thompson PD, Haussler CA, Haussler MR. Molecular nature of the vitamin D receptor and its role in regulation of gene expression. Rev Endocr Metab Disord. 2001;2:203–216. doi: 10.1023/a:1010062929140. [DOI] [PubMed] [Google Scholar]
- 5.Johnson JA, Kumar R. Vitamin D and renal calcium transport. Curr Opin Nephrol Hypertens. 1994;3:424–429. doi: 10.1097/00041552-199407000-00008. [DOI] [PubMed] [Google Scholar]
- 6.Hughes MR, Malloy PJ, O'Malley BW, Pike JW, Feldman D. Genetic defects of the 1,25-dihydroxyvitamin D3 receptor. J Recept Res. 1991;11:699–716. doi: 10.3109/10799899109066437. [DOI] [PubMed] [Google Scholar]
- 7.Kato S, Takeyama K, Kitanaka S, Murayama A, Sekine K, Yoshizawa T. In vivo function of VDR in gene expression-VDR knock-out mice. J Steroid Biochem Mol Biol. 1999;69:247–251. doi: 10.1016/s0960-0760(99)00042-4. [DOI] [PubMed] [Google Scholar]
- 8.Kato S. The function of vitamin D receptor in vitamin D action. J Biochem (Tokyo) 2000;127:717–722. doi: 10.1093/oxfordjournals.jbchem.a022662. [DOI] [PubMed] [Google Scholar]
- 9.Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, Demay MB. Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA. 1997;94:9831–9835. doi: 10.1073/pnas.94.18.9831. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Johnson JA, Grande JP, Roche PC, Kumar R. Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas. Am J Physiol. 1994;267:E356–E360. doi: 10.1152/ajpendo.1994.267.3.E356. [DOI] [PubMed] [Google Scholar]
- 11.Johnson JA, Kumar R. Renal and intestinal calcium transport: Roles of vitamin D and vitamin D-dependent calcium binding proteins. Semin Nephrol. 1994;14:119–128. [PubMed] [Google Scholar]
- 12.Johnson JA, Grande JP, Roche PC, Campbell RJ, Kumar R. Immuno-localization of the calcitriol receptor, calbindin-D28k and the plasma membrane calcium pump in the human eye. Curr Eye Res. 1995;14:101–108. doi: 10.3109/02713689508999921. [DOI] [PubMed] [Google Scholar]
- 13.Johnson JA, Grande JP, Roche PC, Campbell RJ, Kumar R. Immunolocalization of calcitriol receptor, plasma membrane calcium pump and calbindin-D28k in the cornea and ciliary body of the rat eye. Ophthalmic Res. 1995;27:42–47. doi: 10.1159/000267566. [DOI] [PubMed] [Google Scholar]
- 14.Johnson JA, Grande JP, Roche PC, Sweeney WE, Jr, Avner ED, Kumar R. 1 alpha, 25-dihydroxyvitamin D3 receptor ontogenesis in fetal renal development. Am J Physiol. 1995;269:F419–F428. doi: 10.1152/ajprenal.1995.269.3.F419. [DOI] [PubMed] [Google Scholar]
- 15.Johnson JA, Grande JP, Roche PC, Kumar R. Immunohistochemical detection and distribution of the 1,25-dihydroxyvitamin D3 receptor in rat reproductive tissues. Histochem Cell Biol. 1996;105:7–15. doi: 10.1007/BF01450873. [DOI] [PubMed] [Google Scholar]
- 16.Johnson JA, Grande JP, Windebank AJ, Kumar R. 1,25-Dihydroxyvitamin D(3) receptors in developing dorsal root ganglia of fetal rats. Brain Res Dev Brain Res. 1996;92:120–124. doi: 10.1016/0165-3806(95)00204-9. [DOI] [PubMed] [Google Scholar]
- 17.Bills C, Massengale O, Hickman K, Le B, Gray E. A new vitamin D in cod liver oil. J Biol Chem. 1938;126:241–244. [Google Scholar]
- 18.Steenbock H, Kletzien SWF, Halpin JG. The reaction of the chicken to irradiated ergosterol and irradiated yeast as contrasted with the natural vitamin of fish liver oils. J Biol Chem. 1932;97:249–264. [Google Scholar]
- 19.Bills C. The resistance of the anti-rachitic substance in cod liver oil to reagents. J Biol Chem. 1925;64:1–9. [Google Scholar]
- 20.Lu Z, Chen TC, Zhang A, Persons KS, Kohn N, Berkowitz R, Martinello S, Holick MF. An evaluation of the vitamin D3 content in fish: Is the vitamin D content adequate to satisfy the dietary requirement for vitamin D. J Steroid Biochem Mol Biol. 2007;103:642–644. doi: 10.1016/j.jsbmb.2006.12.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Holick MF. Evolutionary biology and pathology of vitamin D. J Nutr Sci Vitaminol (Tokyo) 1992;84:79–83. doi: 10.3177/jnsv.38.special_79. [DOI] [PubMed] [Google Scholar]
- 22.Takeuchi A, Okano T, Sayamoto M, Sawamura S, Kobayashi T, Motosugi M, Yamakawa T. Tissue distribution of 7-dehydrocholesterol, vitamin D3 and 25-hydroxyvitamin D3 in several species of fishes. J Nutr Sci Vitaminol (Tokyo) 1986;32:13–22. doi: 10.3177/jnsv.32.13. [DOI] [PubMed] [Google Scholar]
- 23.Sundell K, Bishop JE, Bjornsson BT, Norman AW. 1,25-Dihydroxyvitamin D3 in the Atlantic cod: Plasma levels, a plasma binding component, and organ distribution of a high affinity receptor. Endocrinology. 1992;131:2279–2286. doi: 10.1210/endo.131.5.1330497. [DOI] [PubMed] [Google Scholar]
- 24.Maglich JM, Caravella JA, Lambert MH, Willson TM, Moore JT, Ramamurthy L. The first completed genome sequence from a teleost fish (Fugu rubripes) adds significant diversity to the nuclear receptor superfamily. Nucleic Acids Res. 2003;31:4051–4058. doi: 10.1093/nar/gkg444. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Suzuki T, Suzuki N, Srivastava AS, Kurokawa T. Identification of cDNAs encoding two subtypes of vitamin D receptor in flounder, Paralichthys olivaceus. Biochem Biophys Res Commun. 2000;270:40–45. doi: 10.1006/bbrc.2000.2378. [DOI] [PubMed] [Google Scholar]
- 26.Reschly EJ, Krasowski MD. Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds. Curr Drug Metab. 2006;7:349–365. doi: 10.2174/138920006776873526. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Whitfield GK, Dang HT, Schluter SF, Bernstein RM, Bunag T, Manzon LA, Hsieh G, Dominguez CE, Youson JH, Haussler MR, Marchalonis JJ. Cloning of a functional vitamin D receptor from the lamprey (Petromyzon marinus), an ancient vertebrate lacking a calcified skeleton and teeth. Endocrinology. 2003;144:2704–2716. doi: 10.1210/en.2002-221101. [DOI] [PubMed] [Google Scholar]
- 28.Ciesielski F, Rochel N, Moras D. Adaptability of the Vitamin D nuclear receptor to the synthetic ligand Gemini: Remodelling the LBP with one side chain rotation. J Steroid Biochem Mol Biol. 2007;103:235–242. doi: 10.1016/j.jsbmb.2006.12.003. [DOI] [PubMed] [Google Scholar]
- 29.Krasowski MD, Yasuda K, Hagey LR, Schuetz EG. Evolutionary selection across the nuclear hormone receptor superfamily with a focus on the NR1I subfamily (vitamin D, pregnane X, and constitutive androstane receptors) Nucl Recept. 2005;3:2. doi: 10.1186/1478-1336-3-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Ciesielski F, Rochel N, Mitschler A, Kouzmenko A, Moras D. Structural investigation of the ligand binding domain of the zebrafish VDR in complexes with 1alpha,25(OH)2D3 and Gemini: Purification, crystallization and preliminary X-ray diffraction analysis. J Steroid Biochem Mol Biol. 2004;89–90:55–59. doi: 10.1016/j.jsbmb.2004.03.109. [DOI] [PubMed] [Google Scholar]
- 31.Qiu A, Glover CN, Hogstrand C. Regulation of branchial zinc uptake by 1alpha,25-(OH)(2)D(3) in rainbow trout and associated changes in expression of ZIP1 and ECaC. Aquat Toxicol. 2007;84:142–152. doi: 10.1016/j.aquatox.2007.02.020. [DOI] [PubMed] [Google Scholar]
- 32.Lock EJ, Ornsrud R, Aksnes L, Spanings FA, Waagbo R, Flik G. The vitamin D receptor and its ligand 1alpha,25-dihydroxyvitamin D3 in Atlantic salmon (Salmo salar) J Endocrinol. 2007;193:459–471. doi: 10.1677/JOE-06-0198. [DOI] [PubMed] [Google Scholar]
- 33.Abbink W, Hang XM, Guerreiro PM, Spanings FA, Ross HA, Canario AV, Flik G. Parathyroid hormone-related protein and calcium regulation in vitamin D-deficient sea bream (Sparus auratus) J Endocrinol. 2007;193:473–480. doi: 10.1677/JOE-06-0164. [DOI] [PubMed] [Google Scholar]
- 34.Fleming A, Sato M, Goldsmith P. High-throughput in vivo screening for bone anabolic compounds with zebrafish. J Biomol Screen. 2005;10:823–831. doi: 10.1177/1087057105279952. [DOI] [PubMed] [Google Scholar]
- 35.Lefebvre KA, Trainer VL, Scholz NL. Morphological abnormalities and sensorimotor deficits in larval fish exposed to dissolved saxitoxin. Aquat Toxicol. 2004;66:159–170. doi: 10.1016/j.aquatox.2003.08.006. [DOI] [PubMed] [Google Scholar]
- 36.Craig TA, Kumar R. Synthesis and purification of soluble ligand binding domain of the human vitamin D3 receptor. Biochem Biophys Res Commun. 1996;218:902–907. doi: 10.1006/bbrc.1996.0160. [DOI] [PubMed] [Google Scholar]
- 37.Veenstra TD, Benson LM, Craig TA, Tomlinson AJ, Kumar R, Naylor S. Metal mediated sterol receptor-DNA complex association and dissociation determined by electrospray ionization mass spectrometry. Nat Biotechnol. 1998;16:262–266. doi: 10.1038/nbt0398-262. [DOI] [PubMed] [Google Scholar]
- 38.Veenstra TD, Johnson KL, Tomlinson AJ, Craig TA, Kumar R, Naylor S. Zinc-induced conformational changes in the DNA-binding domain of the vitamin D receptor determined by electrospray ionization mass spectrometry. J Am Soc Mass Spectrom. 1998;9:8–14. doi: 10.1016/S1044-0305(97)00229-8. [DOI] [PubMed] [Google Scholar]
- 39.Craig TA, Lutz WH, Kumar R. Association of prokaryotic and eukaryotic chaperone proteins with the human 1alpha,25-dihydroxyvitamin D(3) receptor. Biochem Biophys Res Commun. 1999;260:446–452. doi: 10.1006/bbrc.1999.0931. [DOI] [PubMed] [Google Scholar]
- 40.Norman AW, Frankel JB, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science. 1980;209:823–825. doi: 10.1126/science.6250216. [DOI] [PubMed] [Google Scholar]
- 41.Kadowaki S, Norman AW. Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas. J Clin Invest. 1984;73:759–766. doi: 10.1172/JCI111269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Kadowaki S, Norman AW. Pancreatic vitamin D-dependent calcium binding protein: Biochemical properties and response to vitamin D. Arch Biochem Biophys. 1984;233:228–236. doi: 10.1016/0003-9861(84)90621-0. [DOI] [PubMed] [Google Scholar]
- 43.Veenstra TD, Fahnestock M, Kumar R. An AP-1 site in the nerve growth factor promoter is essential for 1, 25-dihydroxyvitamin D3-mediated nerve growth factor expression in osteoblasts. Biochemistry. 1998;37:5988–5994. doi: 10.1021/bi972965+. [DOI] [PubMed] [Google Scholar]
- 44.Veenstra TD, Londowski JM, Windebank AJ, Brimijoin S, Kumar R. Effects of 1,25-dihydroxyvitamin D3 on growth of mouse neuroblastoma cells. Brain Res Dev Brain Res. 1997;99:53–60. doi: 10.1016/s0165-3806(96)00196-4. [DOI] [PubMed] [Google Scholar]
- 45.Veenstra TD, Prufer K, Koenigsberger C, Brimijoin SW, Grande JP, Kumar R. 1,25-Dihydroxyvitamin D3 receptors in the central nervous system of the rat embryo. Brain Res. 1998;804:193–205. doi: 10.1016/s0006-8993(98)00565-4. [DOI] [PubMed] [Google Scholar]
- 46.Prufer K, Veenstra TD, Jirikowski GF, Kumar R. Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord. J Chem Neuroanat. 1999;16:135–145. doi: 10.1016/s0891-0618(99)00002-2. [DOI] [PubMed] [Google Scholar]